Olanzapine and ECT combined therapy in a refractory catatonic subtype schizophrenia. Pedro Gomes de Alvarenga* Sérgio Paulo Rigonatti**
|
|
- Avice Bruce
- 6 years ago
- Views:
Transcription
1 Case report Olanzapine and ECT combined therapy in a refractory catatonic subtype schizophrenia patient with previous neuroleptic malignant syndrome episodes Pedro Gomes de Alvarenga* Sérgio Paulo Rigonatti** * Resident physician. ** PhD, Professor. Responsible for the Electroconvulsive Therapy Service, Psychiatry Institute, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP), SP, Brazil. Received March 28, Revised June 8, Accepted September 6, 2005.
2 INTRODUCTION This is an objective clinical report carried out with information obtained with the patient s family and registered in the patient s record. The study comprises the patient s clinical history and the treatment provided to an adult male patient with catatonic schizophrenia refractory to typical neuroleptic drugs (haloperidol and chlorpromazine) and to another typical agent (risperidone) with two antecedents of neuroleptic malignant syndrome (NMS). The authors treatment of choice was electroconvulsive therapy (ECT) and olanzapine (7.5 mg), which brought considerable benefits to the patient. The association between ECT and an antipsychotic in the control of refractory schizophrenia is reported in the literature. Our goal is to share an effective and safe therapeutic experience in a case that had a high risk for NMS development. CASE REPORT Patient: A 35-year-old single male patient, Caucasian, natural from Presidente Prudente (a town in the state of São Paulo, Brazil), follower of the evangelical church. History of current disease: The patient was referred to the Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo after going to a secondary hospital in his town. He presented with a catatonic status for 15 days characterized by an intense negativism, refusal to eat and mutism, as well as brief episodes of sudden psychomotor agitation and accelerated and uninterrupted speech, when he was hostile to his family and care givers. Previous hospital and drug therapy history His first hospital stay was in 1992, when he was 23 years-old, and suffered with alcohol dependence. He escaped from hospital after 4 days. He was hospitalized five times in a period between 1996 and 2002 for heteroaggressiveness and alcohol dependence. He had NMS after taking oral haloperidol in 2002, when his axillary temperature reached 41 ºC and the creatine phosphokinase enzyme (CPK) was 4,303 u/l. He was discharged from hospital after 32 days with a stable psychotic status, persistent abulia and socially withdrawn. In 2003 he arrived at the hospital again, escorted by policemen. He was wearing superman clothes 2
3 and was extremely aggressive and agitated. As reported by physicians, he talked to himself, had visual, auditory and persecutory delusions that alternated with delusions of grandness. He was administered an ampoule of intramuscular chlorpromazine, carbamazepine 600 mg/day, risperidone 1 mg/day and diazepam 20 mg/day due to the hypothesis of paranoid schizophrenia. The patient developed malignant hyperthermia and extrapyramidal symptoms, requiring a 2-week intensive therapy. He was discharged after 53 days in good clinical conditions except for motor sequelae (forearm and hand extensor deficits) that persist until today. He presented delusive and delirium symptoms refractory to several psychopharmacons administered in therapeutic doses and adequate time, such as haloperidol, levomepromazine, risperidone, valproic acid and phenobarbital. Drugs were administered by the legal responsible (brother) and nurses, therefore, non-compliance was discharged. Personal antecedents and habits: He was born from normal delivery at term, with satisfactory neuropsychomotor development. He studied up to class 6 with many difficulties, after repeating 2 years. He had a few friends and no girlfriend during childhood and adolescence. He said he had some occasional heterosexual relationships. At the age of 18 he started to work as a bricklayer but he was never financially independent. At that time he dressed in a punk style and started to drink alcohol and smoke tobacco frequently. During his adolescence he sporadically tried marijuana, cocaine and mushroom tea. Family history: There is history of alcoholism, depression and mental retardation in firstdegree relatives. Psychic examination on admission (May 2004): Mutism; passive negativism; blunt mood, hipomodulant; hypokinesia and serum flexibility. Clinical and neurological examination: Muscle atrophy and both upper limb extensors deficit. Other aspects were within the boundaries of normal behavior. Lab tests: No relevant findings. 3
4 Imaging examinations: Magnetic resonance imaging of the brain (axial sequential techniques T1, T2, FLAIR, saggital T1 and postgadolinium) showed sulci between the cortical gyri of the frontal lobe and the sylvian brain fissures compliant to a chronic degenerative process. Diagnostic hypothesis: 1) Paranoid/catatonic refractory schizophrenia; 2) Catatonic syndrome; 3) Smoking; 4) Alcohol dependence (for 8 years); 5) Development of dementia process (alcoholic?); 6) History of NMS (two episodes with motor sequealae). Progression during hospital stay: Carbamazepine 800 mg/day prescribed in the service of origin was suspended, and lorazepam 12 mg/day was administered instead, in order to promote muscular relaxation and relief of catatonic symptoms. The patient was administered twelve ECT applications three times a week, under anesthesia, muscular relaxation and under the relative s consent. After the third ECT application, the patient negativism remitted, and he started to present psychomotor elation and delusions of grandness. After completing the 12 applications, the positive symptoms of schizophrenia still persisted and we opted for the gradual and careful introduction of olanzapine. The patient was submitted to other five applications of ECT (total of 17). He then presented total remission of positive symptoms with olanzapine 7.5 mg/day associated to ECT. Cognitive impairment still persisted (attention and fixation memory), decrease of pragmatism and poverty ideation (previously reported in intercritical periods). There were no alterations in CPK, renal or liver functions and glycemia/lipids laboratory examinations. The patient was discharged and referred to the service of ECT for treatment maintenance using olanzapine 7.5 mg, and remained under relatives care. DISCUSSION The reported patient was referred to our ECT service for three basic reasons: 1) catatonic symptoms; 2) risk of being administered powerful high doses of neuroleptic drugs (possibility of NMS recurrence); and 3) clinical refractoriness to antipsychotic drugs, 4
5 Karl Ludwig Kahlbaum firstly described catatonia in 1874 in a monograph entitled Die Katatonie oder Spannungsirrsein. Originally considered an independent disease characterized by deep mental and motor changes, catatonia was later considered a sub-type of schizophrenia, as described in the DSM-IV and IDC Notwithstanding, it is known that catatonia symptoms do not occur specifically in schizophrenic patients, but in a range of psychiatric diseases, such as mood disorders and conversive disorders. 1 Wernicke-Kleist-Leonhard created independent concepts, based on the accurate differences of motor disorders: episodic and systematic or even hyperkinetic and akinetic. 2 Catatonia is a clinical condition that requires prompt treatment, because dehydration and stupor are important complications that can be fatal. 3 Before any psychiatric intervention is performed, a detailed clinical evaluation is indicated in order to avoid electrolytic and metabolic unbalance. 3 The ECT has a fundamental role in the resolution of catatonic symptoms. 4 NMS is a neurotoxic state that may be fatal. It occurs in about 0.2% of patients managed with neuroleptic drugs. The ideal approach to NMS includes treatment in ICUs. 5 Known risk factors are: agitation, dehydration and high doses of powerful neuroleptic drugs. 5 Hyperthermia, disautonomy, mental confusion and stiffness are diagnostic patterns. 5 CPK enzyme elevation is a lab data that helps in the diagnosis. Recurrence of NMS is very frequent, therefore it is advisable to administer safe drugs and perform careful titration. 5 The ECT becomes an important strategy in these cases. 5 Refractoriness to antipsychotic agents (absence of satisfactory clinical response to more than two distinct classes of neuroleptics, administered with proper time and dose) 6 is not rare in the psychiatric practice, and such conditions were found in the case we are reporting. The three situations presented 1) catatonic syndrome; 2) NMS; and 3) refractoriness to antipsychotics are accurate indications for the ECT application, which resulted a satisfactory clinic response and a few side effects already expected (headache and transient amnesia). After the 12 ECT applications, the catatonic symptoms remitted but the delusions of grandness and residual persecutory delusions persisted. The association between ECT and an antipsychotic has been showing positive results in the control of positive symptoms of treatment-refractory 5
6 schizophrenia. 7,8 We opted for the gradual and careful introduction of olanzapine, because the patient had already presented NMS with the use of typical neuroleptics (haloperidol and chlorpromazine) and poor clinical response to another atypical agent (risperidone). The literature 9,10 reports on cases of NMS triggered by atypical antipsychotic agents, among them there is olanzapine. This is the reason why the dose administered was carefully increased, always considering the least effective dose. Submitted to additional applications of ECT (total of 17) and in use of olanzapine 7.5 mg/day he presented total remission of positive symptoms. The patient continued with the negative symptoms such as cognitive deficits, hypobulia, affective stupor and poor ideations, which were already expected, once the combination of a psychopharmacon with ECT was shown to have a low impact on the control of negative symptoms. 8 The literature 11 points out the efficacy of maintenance ECT to decrease the psychotic symptoms relapse and the number of hospitalizations of psychiatric patients. It has been providing excellent outcomes in our service. The association between neuroleptics and ECT has been successfully employed. Although there are reports of NMS triggered by atypical agents, the association between olanzapine (7.5 mg) and ECT has been a safe choice in cases of refractory catatonic subtype schizophrenia with high risk for NMS development. 6
7 REFERENCES 1. Pfuhlmann B, Stober G. The different conceptions of catatonia: historical overview and critical discussion. Eur Arch Psychiatry Clin Neurosci. 2001;251(1): Starkstein SE, Goldar JC, Hodgkiss A. Karl Ludwig Kahlbaum s concept of catatonia. Hist Psychiatry. 1995;6(22 pt 2): Pommepuy N, Januel D. Catatonia: resurgence of a concept. A review of the international literature. Encephale. 2002;28(6 Pt 1): Rohland BM, Carroll BT, Jacoby RG. ECT in the treatment of the catatonic syndrome. J Affect Disord. 1993;29(4): Francis A, Chandragiri S, Petrides G. Risk factors for neuroleptic malignant syndrome. Am J Psychiatry. 1998;155(11): Koshino Y. Algorithm for treatment-refractory schizophrenia. Psychiatry Clin Neurosci. 1999;53(Suppl):S Tang WK, Ungvari GS. Efficacy of electroconvulsive therapy combined with antipsychotic medication in treatment-resistant schizophrenia: a prospective open trial. J ECT. 2002;18(2): Chanpattana W, Chakrabhand ML. Combined ECT and neuroleptic therapy in treatmentrefractory schizophrenia: prediction of outcome. Psychiatry Res. 2001;105(1-2): Hanft A, Eggleston CF, Bourgeois JA. Neuroleptic malignant syndrome in an adolescent after brief exposure to olanzapine. J Child Adolesc Psychopharmacol. 2004;14(3): Kogoj A, Velikonja I. Olanzapine induced neuroleptic malignant syndrome: a case review. Hum Psychopharmacol. 2003;18(4): Chanpattana W. Continuation electroconvulsive therapy in schizophrenia: a pilot study. J Med Assoc Thai. 1997;80(5):
8 ABSTRACT This article describes the clinical history and management of an adult male patient with refractory catatonic schizophrenia to two typically used neurolpetic medications (haloperidol and chlorpromazine) and to another atypical agent (risperidone).the patient had also presented two neuroleptic malignant syndrome episodes due to typical neuroleptic agents. The authors combined ECT and olanzapine (7.5 mg) as treatment, and a considerable clinical improvement was obtained. Keywords: ECT, olanzapine, catatonia. Title: Olanzapine and ECT combined therapy in a refractory catatonic subtype schizophrenia patient with previous neuroleptic malignant syndrome episodes Correspondence: Pedro Gomes de Alvarenga/Sérgio Paulo Rigonatti Rua Ovídeo Pires de Campos, 870 São Paulo SP Brazil Phone: (+55-11) pedroalva@protoc.com.br 8
Neuroleptic malignant syndrome (NMS) was first
Case Report 576 Severe Neuroleptic Malignant Syndrome: Successful Treatment with High-dose Lorazepam and Diazepam: A Case Report Meng-Chang Tsai, MD; Tiao-Lai Huang, MD Neuroleptic malignant syndrome (NMS)
More informationPeriodic catatonia with long-term treatment: a case report
Chen and Huang BMC Psychiatry (2017) 17:337 DOI 10.1186/s12888-017-1497-6 CASE REPORT Open Access Periodic catatonia with long-term treatment: a case report Ruei-An Chen and Tiao-Lai Huang * Abstract Background:
More informationCatatonia a forgotten but not extinct condition
NACT meeting 2016 Catatonia a forgotten but not extinct condition Tom G. Bolwig Professor emeritus, dr.med University of Copenhagen What is Catatonia? Catatonia is a motor dysregulation syndrome among
More informationAre they still doing that?
Are they still doing that? Why we still give ECT and when to refer Nicol Ferrier BSc (Hons), MD, FRCP(Ed), FRCPsych Emeritus Professor of Psychiatry Newcastle University Rates of prescribing ECT in the
More informationSchizophrenia and Other Psychotic Disorders
Schizophrenia and Other Psychotic Disorders Chapter 14 This multimedia product and its contents are protected under copyright law. The following are prohibited by law: any public performance or display,
More informationNeuroleptic malignant syndrome induced by atypical neuroleptics and responsive to lorazepam. Introduction
CASE REPORT Neuroleptic malignant syndrome induced by atypical neuroleptics and responsive to lorazepam Adeeb Yacoub Andrew Francis Department of Psychiatry and Behavioral Science, School of Medicine,
More informationPsychotic Disorders. Schizophrenia. Age Distribution of Onset 2/24/2009. Schizophrenia. Hallmark trait is psychosis
Psychotic Disorders Schizophrenia Schizophrenia Affects people from all walks of life Is about as prevalent as epilepsy Usually begins in late adolescence or early adulthood Hallmark trait is psychosis
More informationPsychotic disorders Dr. Sarah DeLeon, MD PGYIV, Psychiatry ConceptsInPsychiatry.com
Psychotic disorders Dr. Sarah DeLeon, MD PGYIV, Psychiatry ConceptsInPsychiatry.com Introduction Psychotic spectrum disorders include schizotypal personality disorder, delusional disorder, brief psychotic
More informationCASE 5 - Toy & Klamen CASE FILES: Psychiatry
CASE 5 - Toy & Klamen CASE FILES: Psychiatry A 14-year-old boy is brought to the emergency department after being found in the basement of his home by his parents during the middle of a school day. The
More informationHelp and Healing: Section 2: Treatment Planning. Treatment and Timelines. Depression Treatment Reference. Care Team Communication
Help and Healing: Resources for Depression Care and Recovery Section 2: Treatment Planning Treatment and Timelines Depression Treatment Reference Care Team Communication Provider Education Tool - Questions
More informationCognitive disorders. Dr S. Mashaphu Department of Psychiatry
Cognitive disorders Dr S. Mashaphu Department of Psychiatry Delirium Syndrome characterised by: Disturbance of consciousness Impaired attention Change in cognition Develops over hours-days Fluctuates during
More information8/22/2016. Contemporary Psychiatric-Mental Health Nursing Third Edition. Features of Schizophrenia. Features of Schizophrenia (cont'd)
Contemporary Psychiatric-Mental Health Nursing Third Edition CHAPTER 16 Schizophrenia Features of Schizophrenia Prevalence in U.S. is 1.1%. Average onset is late teens to early twenties, but can be as
More informationECT in Schizophrenia. Dr Richard Braithwaite Consultant Psychiatrist Isle of Wight NHS Trust
ECT in Schizophrenia Dr Richard Braithwaite Consultant Psychiatrist Isle of Wight NHS Trust ECT in Schizophrenia (not catatonia) Dr Richard Braithwaite Consultant Psychiatrist Isle of Wight NHS Trust Objectives
More informationChapter 12. Schizophrenia and Other Psychotic Disorders. PSY 440: Abnormal Psychology. Rick Grieve Western Kentucky University
Chapter 12 Schizophrenia and Other Psychotic Disorders PSY 440: Abnormal Psychology Rick Grieve Western Kentucky University psychotic disorders disorders so severe that the person has essentially lost
More informationDementia With A Twist
Dementia With A Twist Christina Tieu Geriatric Update for the Primary Care Provider November 17 th, 2016 2016 MFMER slide-1 79 y/o woman originally from Greece CC: paranoia, abulia and mutism Accompanied
More informationContemporary Psychiatric-Mental Health Nursing. Features of Schizophrenia. Features of Schizophrenia - continued
Contemporary Psychiatric-Mental Health Nursing Chapter 16 Schizophrenia and Other Psychotic Disorders Features of Schizophrenia Prevalence in U.S. is 1.1%. Average onset is late teens to early twenties,
More informationVI.2 Elements for a public summary. VI.2.1 Overview of disease epidemiology
VI.2 Elements for a public summary VI.2.1 Overview of disease epidemiology Incidence and prevalence of target indication Schizophrenia is a mental disorder characterized by a breakdown of thought processes
More informationIs The Routine CT Head Scan Justified for Psychiatric Patients? A Prospective Study
RESEARCH PAPERS Is The Routine CT Head Scan Justified for Psychiatric Patients? A Prospective Study Jambur Ananth, M.D., Reda Gamal, M.D., Milton Miller, M.D., Marcy Wohl, R.N., Steven Vandewater, Ph.D.
More informationSchizophrenia. Introduction. Overview and Facts
Introduction is a chronic, severe and disabling brain disease that typically shows its first clear symptoms in late adolescence or early adulthood. It is one of several types of Psychotic Disorders. It
More informationSchizophrenia. Can someone be psychotic without having schizophrenia? 11/30/2008. Name that Psychotic Disorder! Other psychotic disorders and causes
Schizophrenia Other psychotic disorders and causes Name that Psychotic Disorder! Chris has started spending large amounts of time guarding his home. They have bugged his phone and are sending cars past
More informationProvider Bulletin Philadelphia Department of Behavioral Health Community Behavioral Health State Allowable ICD-9-CM Codes.
Provider Bulletin 07-01 Philadelphia Department of Behavioral Health Community Behavioral Health State Allowable ICD-9-CM Codes. February 12, 2007 The Commonwealth of Pennsylvania lists the allowable ICD-9-CM
More informationSCHIZOPHRENIA SPECTRUM DISORDERS Psychiatry 2 Practical # 2
Psychiatrická klinika LFUK a UNB, Bratislava SCHIZOPHRENIA SPECTRUM DISORDERS Psychiatry 2 Practical # 2 Author: MUDr. Ľubomíra Izáková, PhD. Supervisor: doc. MUDr. Ján Pečeňák, CSc. Podporené grantom
More informationSchizophrenia. Class Objectives. Can someone be psychotic without having schizophrenia? 12/7/2011. Other psychotic disorders and causes
Schizophrenia Other psychotic disorders and causes Class Objectives What are Delusional Disorders? What causes Schizophrenia? How can Schizophrenia be treated? Can someone be psychotic without having schizophrenia?
More informationChapter 12 1/29/2018. Schizophrenia and Schizophrenia Spectrum Disorders. Epidemiology. Comorbidity. Lifetime prevalence of schizophrenia is 1%
Chapter 12 Schizophrenia and Schizophrenia Spectrum Disorders Epidemiology Lifetime prevalence of schizophrenia is 1% No difference related to 2 Comorbidity Substance abuse disorders Anxiety, depression,
More informationSchizophrenia FAHAD ALOSAIMI
Schizophrenia FAHAD ALOSAIMI MBBS, SSC - PSYCH C ONSULTATION LIAISON PSYCHIATRIST K ING SAUD UNIVERSITY Schizophrenia - It is not a single disease but a group of disorders with heterogeneous etiologies.
More informationCambridge University Press Effective Treatments in Psychiatry Peter Tyrer and Kenneth R. Silk Excerpt More information
Organic disorders 1 Delirium Based on Delirium by Laura Gage and David K. Conn in Effective Treatments in Psychiatry, Cambridge University Press, 2008 Introduction Delirium needs treatment for both its
More informationTable of substance use disorder diagnoses:
Table of substance use disorder diagnoses: ICD-9 Codes Description 291 Alcohol withdrawal delirium 291.3 Alcohol-induced psychotic disorder with hallucinations 291.4 Idiosyncratic alcohol intoxication
More informationPsychosis, Mood, and Personality: A Clinical Perspective
Psychosis, Mood, and Personality: A Clinical Perspective John R. Chamberlain, M.D. Assistant Director, Psychiatry and the Law Program Assistant Clinical Professor University of California San Francisco
More informationElements for a Public Summary. VI.2.1 Overview of disease epidemiology
VI.2 Elements for a Public Summary VI.2.1 Overview of disease epidemiology Schizophrenia Schizophrenia is a mental disorder often characterized by abnormal social behaviour and failure to recognize what
More informationSiGMA/ MMHSCT GUIDELINES FOR ANTIPSYCHOTIC DRUG TREATMENT OF SCHIZOPHRENIA. [compatible with NICE guidance]
SiGMA/ MMHSCT GUIDELINES FOR ANTIPSYCHOTIC DRUG TREATMENT OF SCHIZOPHRENIA [compatible with NICE guidance] Medicines Management Committee August 2002 For review August 2003 Rationale The SiGMA algorithm
More informationPsychopharmacology in the Emergency Room. Michael D. Jibson, M.D., Ph.D. Associate Professor of Psychiatry University of Michigan
Psychopharmacology in the Emergency Room Michael D. Jibson, M.D., Ph.D. Associate Professor of Psychiatry University of Michigan Pretest 1. Appropriate target symptoms for emergency room medication treatment
More informationDISEASES AND DISORDERS
DISEASES AND DISORDERS 13. The mood (affective) disorders 99 14. The psychotic disorders: schizophrenia 105 15. The anxiety and somatoform disorders 111 16. Dementia and delirium 117 17. Alcohol and substance-related
More informationSchizophrenia. Psychology 372 Physiological Psychology. Overview. Characterized by. Disorganized Thoughts Hallucinations Delusions Bizarre behaviors
Overview Schizophrenia Psychology 372 Physiological Psychology Steven E. Meier, Ph.D. Listen to the audio lecture while viewing these slides Probably consists of more than one disorder Is the most devastating
More informationSuccessful treatment of catatonic syndrome in bipolar I disorder adding aripiprazole to ECT: A case report
Eur. J. Psychiat. Vol. 26, N. 3, (169-173) 2012 Short report Keywords: Catatonia; Aripiprazole; Second generation antipsychotics; ECT; Bipolar disorder. Successful treatment of catatonic syndrome in bipolar
More informationWorking with Clients Experiencing a First Episode of Psychosis: Considerations for Prescribers
Working with Clients Experiencing a First Episode of Psychosis: Considerations for Prescribers Tuesday, February 23, 2016 2pm Eastern Delbert Robinson, M.D. Professor of Psychiatry and Molecular Medicine
More informationD. Exclusion of schizoaffective disorder and mood disorder with psychotic features.
65 CHAPTER 8: APPENDIX. ADDENDUM A DSM-IV diagnostic criteria for schizophrenia A. Characteristic symptoms: Two or more of the following, each present for a significant portion of time during a one-month
More informationAlcoholism. Psychiatry. Alcoholism. Alcoholism. Certification. Certification
Alcoholism Psychiatry Liz Clark, D.O., MPH & TM FAOCOPM MY-2012 Except where absolute criteria exist (i.e., a current clinical diagnosis of alcoholism), as a medical examiner, you make the final determination
More informationDosing & Administration
Dosing & Administration REAL LIFE. REAL RESULTS. INDICATION INVEGA SUSTENNA (paliperidone palmitate) is indicated for the treatment of: Schizophrenia. Schizoaffective disorder as monotherapy and as an
More informationTreatment of Schizophrenia
Treatment of Schizophrenia Conduct comprehensive assessment and use measurement-based care as found in the Principles of Practice (review pages 4-7). Most importantly assess social support system (housing,
More informationRapid Relief of Catatonia in Mood Disorder by Lorazepam and Diazepam. Yu Chi Huang, Chin Chuen Lin, Yi Yung Hung, Tiao Lai Huang
Original Article Rapid Relief of Catatonia in Mood Disorder by Lorazepam and Diazepam Yu Chi Huang, Chin Chuen Lin, Yi Yung Hung, Tiao Lai Huang Background: Catatonia has risks of severe morbidity and
More informationPROBABLE HEALTH CONSEQUENCES OF NOT TAKING THIS MEDICATION
University Health System PSYCHIATRIC SERVICES ANTIPSYCHOTICS Atypical Neuroleptics Risperdal (Risperidone ) Olanzapine (Zyprexa ) Quetiapine (Seroquel ) Course of Treatment: PURPOSE AND GENERAL INFORMATION
More informationPRESCRIBING GUIDELINES
The Maudsley The South London and Maudsley NHS Foundation Trust & Oxleas NHS Foundation Trust PRESCRIBING GUIDELINES 10th Edition David Taylor Carol Paton Shitij Kapur informa healthcare Contents Authors
More informationPsychotropic Drugs 0, 4-
0, 4- } -v Psychotropic Drugs NORMAN L. KELTNER, Ed D, RN Associate Professor, Graduate Program, University of Alabama School of Nursing, University of Alabama at Birmingham, Birmingham, Alabama DAVID
More informationChapter 15: Late Life and Psychological Disorders
\ Chapter 15: Late Life and Psychological Disorders 1. Ageism refers to a. the physical deterioration that accompanies old age. b. the intellectual deterioration that frequently occurs as a person ages.
More informationManagement of the Acutely Agitated Long Term Care Patient
Management of the Acutely Agitated Long Term Care Patient 80 60 Graying of the Population US Population Over Age 65 Millions of Persons 40 20 0 1900 1920 1940 1960 1980 1990 2010 2030 Year Defining Dementia
More informationSchizophrenia and schizophrenia-like disorders
Schizophrenia and schizophrenia-like disorders Dr: Weibo Liu E-mail:liuweibo1020@163.com The Second Affiliated Hospital Zhejiang University College of Medicine Category of psychotic disorders Schizophrenia
More informationCOALINGA STATE HOSPITAL. Effective Date: August 31, 2006
COALINGA STATE HOSPITAL NURSING POLICY AND PROCEDURE MANUAL SECTION Emergency Procedures POLICY NUMBER: 717 Effective Date: August 31, 2006 SUBJECT: NEUROLEPTIC MALIGNANT SYNDROME 1. PURPOSE: To provide
More informationECT in children and adolescents
ECT in children and adolescents Adi Sharma MD MRCPsych PhD Clinical Senior Lecturer & Hon Consultant in Child & Adolescent Psychiatry National Adolescent Bipolar Service 1 Conflicts None relevant to this
More informationReview: Psychosocial assessment and theories of development from N141 and Psych 101
Unit III Theory and Practice of Psychiatric Nursing REQUIRED READINGS AND ACTIVITIES Related Activities Assignments Review: Psychosocial assessment and theories of development from N141 and Psych 101 Anxiety,
More informationMental Health Disorders Civil Commitment UNC School of Government
Mental Health Disorders 2017 Civil Commitment UNC School of Government Edward Poa, MD, FAPA Chief of Inpatient Services, The Menninger Clinic Associate Professor, Baylor College of Medicine NC statutes
More informationLiz Clark, D.O., MPH & TM FAOCOPM
Liz Clark, D.O., MPH & TM FAOCOPM Except where absolute criteria exist (i.e., a current clinical diagnosis of alcoholism), as a medical examiner, you make the final determination as to whether the driver
More informationRole of Clozapine in Treatment-Resistant Schizophrenia
Disease Management and Treatment Strategies Elkis H, Meltzer HY (eds): Therapy-Resistant Schizophrenia. Adv Biol Psychiatry. Basel, Karger, 2010, vol 26, pp 114 128 Role of Clozapine in Treatment-Resistant
More informationTreatment Options for Bipolar Disorder Contents
Keeping Your Balance Treatment Options for Bipolar Disorder Contents Medication Treatment for Bipolar Disorder 2 Page Medication Record 5 Psychosocial Treatments for Bipolar Disorder 6 Module Summary 8
More informationPsychosis and Agitation in Dementia
Psychosis and Agitation in Dementia Dilip V. Jeste, MD Estelle & Edgar Levi Chair in Aging, Director, Stein Institute for Research on Aging, Distinguished Professor of Psychiatry & Neurosciences, University
More informationSchizophrenia. Positive Symptoms. Course of Schizophrenia. Psychotic Disorder
Schizophrenia Kimberley Clow kclow2@uwo.ca http://instruct.uwo.ca/psychology/155b/ Outline What is Schizophrenia? Positive Symptoms Negative Symptoms Subtypes Phases Development Causes Treatment What Is
More informationAre All Older Adults Depressed? Common Mental Health Disorders in Older Adults
Are All Older Adults Depressed? Common Mental Health Disorders in Older Adults Cherie Simpson, PhD, APRN, CNS-BC Myth vs Fact All old people get depressed. Depression in late life is more enduring and
More informationOF THE ILLNESS. Manote Lotrakul. Aug 2015
SCHIZOPHRENIA: ALL PHASES OF THE ILLNESS Manote Lotrakul Aug 2015 Outline Diagnostic criteria Clinical features Treatments DSM-5 : Schizophrenia A. Two (or more) of the following, each present for a significant
More informationSynthetic Marijuana and Current Treatment: A Literature Review
Synthetic Marijuana and Current Treatment: A Literature Review Nimmy Thomas* Psychiatric Nurse Practitioner at PACE Mental Health, USA Review Article Received date: 30/01/2019 Accepted date: 18/03/2019
More informationThe New Clinical Science of ECT
The New Clinical Science of ECT C. Edward Coffey, MD Professor of Psychiatry & Behavioral Sciences, and of Neurology Baylor College of Medicine Houston, Texas Fellow and Past President, International Society
More information9/3/2014. Contemporary Psychiatric-Mental Health Nursing Third Edition. Features of Schizophrenia. Features of Schizophrenia (cont'd)
Contemporary Psychiatric-Mental Health Nursing Third Edition CHAPTER 16 Schizophrenia Features of Schizophrenia Prevalence in U.S. is 1.1%. Average onset is late teens to early twenties, but can be as
More informationThe treatment of bipolar disorder in adults, children and adolescents
DRAFT FOR CONSULTATION The treatment of bipolar disorder in adults, children and adolescents The paragraphs in the draft are numbered for the purposes of consultation. The final version will not contain
More informationKelly Godecke, MD Department of Psychiatry University of Utah
Kelly Godecke, MD Department of Psychiatry University of Utah Epidemiology and Impact -module 2 session 1 overview of mood disorders Diagnostic Criteria of Bipolar Disorders Medications Used in Bipolar
More informationGoal: To recognize and differentiate different forms of psychopathology that involve disordered thinking and reasoning and distorted perception
Goal: To recognize and differentiate different forms of psychopathology that involve disordered thinking and reasoning and distorted perception Psychotic disorders, or psychoses, are among the most serious
More informationCHAPTER 3. Schizophrenia and Antipsychotic Treatment
CHAPTER 3 Schizophrenia and Antipsychotic Treatment What is it? It is a severe, chronic, disabling brain disease Considered to have biological origins but exact unknown 1% of population affected Schizophrenia
More informationA Basic Approach to Mood and Anxiety Disorders in the Elderly
A Basic Approach to Mood and Anxiety Disorders in the Elderly November 1 2013 Sarah Colman MD FRCPC Clinical Fellow, Geriatric Psychiatry Mount Sinai Hospital, University of Toronto Disclosure No conflict
More informationDelirium. Assessment and Management
Delirium Assessment and Management Goals and Objectives Participants will: 1. be able to recognize and diagnose the syndrome of delirium. 2. understand the causes of delirium. 3. become knowledgeable about
More informationADMINISTRATIVE POLICY AND PROCEDURE
Page 1 of 6 SECTION: Medical SUBJECT: Electroconvulsive Therapy (ECT) DATE OF ORIGIN: 10/1/96 REVIEW DATES: 7/1/98, 10/1/99, 7/1/02, 7/1/04, 10/1/05, 5/1/09, 1/3/13, 7/1/15, 8/1/16 EFFECTIVE DATE: 3/24/17
More informationPsychotic Disorders. There is a loss of contact with and difficulty in recognizing reality.
Psychotic Disorders A psychosis or psychotic disorder, involves a major disorganization of thought processes, confused and extreme emotional responses, and distorted perceptions of the world. There is
More informationProfessor Tony Holland, Department of Psychiatry, University of Cambridge
INFORMATION SHEET The Use of Medication for Challenging Behaviour Professor Tony Holland, Department of Psychiatry, University of Cambridge Introduction Challenging behaviours displayed by people with
More informationClinical Guidelines for the Pharmacologic Treatment of Schizophrenia
Clinical Guidelines for the Pharmacologic Treatment of Community Behavioral Health (CBH) is committed to working with our provider partners to continuously improve the quality of behavioral healthcare
More informationSchizophrenia and the Psychoses
Schizophrenia and the Psychoses Taking leave of one s senses Students of schizophrenia need to study and understand: Clinical presentation via case studies Terms and Definitions Biological features Prognosis
More informationIEHP UM Subcommittee Approved Authorization Guidelines Electroconvulsive Therapy- ECT
Electroconvulsive Therapy- ECT Policy: IEHP considers ECT medically necessary for members with the following disorders: 1. Unipolar and bipolar depression. 2. Bipolar mania. 3. Psychotic disorders including
More informationDELIRIUM. Approach and Management
DELIRIUM Approach and Management By Dr. K.S. Jacob, Professor of Psychiatry and Dr. Anju Kuruvilla, Professor of Psychiatry, Christian Medical College, Vellore. Based on a chapter in the book Psychiatric
More informationDEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.
DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017. Introduction. Parkinson's disease (PD) has been considered largely as a motor disorder. It has been increasingly recognized that
More informationSchizophrenia and other psychotic disorders
Schizophrenia and other psychotic disorders Psychosis, schizophrenia What does psychosis mean? What does schizophrenia mean? Is there any difference between them? Psychosis, schizophrenia Psychosis: -
More informationAffective Disorders.
Affective Disorders http://www.bristol.ac.uk/medicalschool/hippocrates/psychethics/ Affective Disorders Depression Mania / Hypomania Bipolar mood disorder Recurrent depression Persistent mood disorders
More informationSYNOPSIS. Trial No.: RIS-USA-70 Clinical phase: III. JRF, Clinical Research Report RIS-USA-70, 16 October, 1998 N Trial period: Start: 20 Nov 95
SYNOPSIS Trial identification and protocol summary Company: Janssen Research Foundation Finished product: RISPERDAL Active ingredient: Risperidone (R064,766) Title: An open-label, long-term study of risperidone
More informationDepression A Review For Primary Care. Marija Petrovic, MD
Depression A Review For Primary Care Marija Petrovic, MD Grand Rounds: 2/22/2017 Please sign the attendance sheet in the room to claim your credit. Kaiser Permanente South San Francisco has determined
More informationBipolar Disorder 4/6/2014. Bipolar Disorder. Symptoms of Depression. Mania. Depression
Bipolar Disorder J. H. Atkinson, M.D. Professor of Psychiatry HIV Neurobehavioral Research Programs University of California, San Diego KETHEA, Athens Slides courtesy of John Kelsoe, M.D. Bipolar Disorder
More informationDelirium. A Plan to Reduce Use of Restraints. David Wensel DO, FAAHPM Medical Director Midland Care
Delirium A Plan to Reduce Use of Restraints David Wensel DO, FAAHPM Medical Director Midland Care Objectives Define delirium Describe pathophysiology of delirium Understand most common etiologies Define
More informationThe Maudsley Prescribing Guidelines in
The Maudsley Prescribing Guidelines in 11th Edition David Taylor Director of Pharmacy and Pathology South London and Maudsley NHS Foundation Trust; Professor King's College London, London, UK Paton Chief
More informationAntipsychotic Medications
TRAIL: Team Review of EVIDENCE REVIEW & RECOMMENDATIONS FOR LTC Behavioural and psychological symptoms of dementia (BPSD) refer to the non-cognitive symptoms of disturbed perception, thought content, mood
More informationSchizophrenia. Can someone be psychotic without having schizophrenia? 12/2/2007. Name that Psychotic Disorder! Other psychotic disorders and causes
Schizophrenia Other psychotic disorders and causes Name that Psychotic Disorder! Chris has started spending large amounts of time guarding his home. They have bugged his phone and are sending cars past
More informationLAI Antipsychotics Frequently Asked Questions
LAI Antipsychotics Frequently Asked Questions Click each question to see the answer. Click the link to return to this list. Who should receive LAIs (long acting injectable antipsychotics)? Which antipsychotics
More informationDepartment of Public Welfare PSYCHOLOGICAL IMPAIRMENT REPORT
Department of Public Welfare PSYCHOLOGICAL IMPAIRMENT REPORT The purpose of this report is to outline the information needed to make a disability determination. This is not a required format; however,
More informationEarly Stages of Psychosis. Learning Objectives
Early Stages of Psychosis Stephan Heckers, MD MSc Department of Psychiatry and Behavioral Sciences Vanderbilt University Learning Objectives Summarize the five domains of psychosis Describe how psychotic
More informationA Case Report and Literature Review. Supplementary Material
1 Periodic Catatonia Marked by Hypercortisolemia and Exacerbated by the Menses: A Case Report and Literature Review Samantha Zwiebel, M.D., Alejandro G Villasante-Tezanos, M.Sc., and Jose de Leon, M.D.
More informationShared Care Guideline for Olanzapine (Zyprexa )
Shared Care Guideline for Olanzapine (Zyprexa ) Development Process This guidance has been produced by Sarah Hudson Lead Pharmacist SWYPFT following an AMBER classification status of Olanzapine by the
More informationASAM Criteria, Third Edition Matrix for Matching Adult Severity and Level of Function with Type and Intensity of Service
1: Acute Intoxication and/or Withdrawal Potential Risk Rating: 0 1: Acute Intoxication and/or Withdrawal Potential Risk Rating: 1 1: Acute Intoxication and/or Withdrawal Potential Risk Rating: 2 The patient
More informationPreferred Practice Guidelines Bipolar Disorder in Children and Adolescents
BadgerCare Plus Preferred Practice Guidelines Bipolar Disorder in Children and Adolescents These Guidelines are based in part on the following: American Academy of Child and Adolescent Psychiatry s Practice
More informationAging with Bipolar Disorder. Neha Jain, MD, FAPA Assistant Professor of Psychiatry, UConn Health
Aging with Bipolar Disorder Neha Jain, MD, FAPA Assistant Professor of Psychiatry, UConn Health Objectives Define bipolar disorder in the elderly Review comorbidities How does it differ from bipolar in
More informationΝευροφυσιολογία και Αισθήσεις
Biomedical Imaging & Applied Optics University of Cyprus Νευροφυσιολογία και Αισθήσεις Διάλεξη 19 Ψυχασθένειες (Mental Illness) Introduction Neurology Branch of medicine concerned with the diagnosis and
More informationSome newer, investigational approaches to treating refractory major depression are being used.
CREATED EXCLUSIVELY FOR FINANCIAL PROFESSIONALS Rx FOR SUCCESS Depression and Anxiety Disorders Mood and anxiety disorders are common, and the mortality risk is due primarily to suicide, cardiovascular
More informationMODEL PSYCHOPHARMACOLOGY CURRICULUM
Third Edition MODEL PSYCHOPHARMACOLOGY CURRICULUM For Psychiatric Residency Programs, Training Directors and Teachers of Psychopharmacology VOLUME I By A Committee of the American Society of Clinical Psychopharmacology
More informationComparison of Catatonia Presentation in Patients with Schizophrenia and Mood Disorders in Lagos, Nigeria. Original Article
Original Article Comparison of Catatonia Presentation in Patients with Schizophrenia and Mood Disorders in Lagos, Nigeria Dada Mobolaji Usman, MBChB, MSc (Epid), FMCPsy 1 Okewole Adeniran Olubunmi, MBBS
More informationPsychosis. Paula Gibbs, MD Department of Psychiatry University of Utah
Psychosis Paula Gibbs, MD Department of Psychiatry University of Utah Psychotic Symptoms Psychosis in a broad sense, signifies impaired reality testing ability Symptoms include: hallucinations, delusions,
More informationACOEM Commercial Driver Medical Examiner Training Program
ACOEM Commercial Driver Medical Examiner Training Program Module 7: Psychological Psychological 49 CFR 391.41(b)(9) "A person is physically qualified to drive a commercial motor vehicle if that person
More informationClozapine-induced concordant agranulocytosis
Ó 2001 Martin Dunitz Ltd International Journal of Psychiatry in Clinical Practice 2001 Volume 5 Pages 71 ± 73 71 Clozapine-induced concordant agranulocytosis in monozygotic twins J HORAÂ C Ï EK, J LIBIGER,
More informationChapter 17. Psychoses. Classifications of Psychoses. Schizophrenia. Factors Attributed to Development of Psychoses
Chapter 17 Psychoses Drugs for Psychoses Delusions Hallucinations Illusions Paranoia Upper Saddle River, New Jersey 07458 All rights reserved. Classifications of Psychoses Acute episode Chronic episode
More information